KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Globus Medical (GMED) over the last 14 years, with Q3 2025 value amounting to $646.7 million.

  • Globus Medical's Accumulated Depreciation & Amortization rose 2780.38% to $646.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $646.7 million, marking a year-over-year increase of 2780.38%. This contributed to the annual value of $545.8 million for FY2024, which is 2821.06% up from last year.
  • As of Q3 2025, Globus Medical's Accumulated Depreciation & Amortization stood at $646.7 million, which was up 2780.38% from $601.8 million recorded in Q2 2025.
  • Globus Medical's Accumulated Depreciation & Amortization's 5-year high stood at $646.7 million during Q3 2025, with a 5-year trough of $282.3 million in Q1 2021.
  • Over the past 5 years, Globus Medical's median Accumulated Depreciation & Amortization value was $364.2 million (recorded in 2023), while the average stood at $411.8 million.
  • As far as peak fluctuations go, Globus Medical's Accumulated Depreciation & Amortization surged by 969.73% in 2022, and later skyrocketed by 3186.99% in 2024.
  • Globus Medical's Accumulated Depreciation & Amortization (Quarter) stood at $305.6 million in 2021, then grew by 12.26% to $343.0 million in 2022, then grew by 24.1% to $425.7 million in 2023, then increased by 28.21% to $545.8 million in 2024, then rose by 18.48% to $646.7 million in 2025.
  • Its Accumulated Depreciation & Amortization was $646.7 million in Q3 2025, compared to $601.8 million in Q2 2025 and $571.7 million in Q1 2025.